Thrombolytic therapy

Subarachnoid haemorrhage - Thrombolytic therapy Factor

Last reviewed for CCPS 17 December 2003.

Preliminary questions [14114]

14159 there is some evidence that undergoing thrombolytic therapy may be a factor in the development of the condition under consideration.

12738 the veteran has undergone thrombolytic therapy at some time.

14160

the veteran was undergoing thrombolytic therapy at the time of the clinical onset of the condition under consideration.

28543

the veteran was undergoing thrombolytic therapy at the time of the clinical onset of the condition under consideration for treatment of an illness or injury which is identifiable.

14161 — the veteran has established the causal connection between the thrombolytic therapy and VEA service for the clinical onset of subarachnoid haemorrhage.

14162 — the veteran has established the causal connection between the thrombolytic therapy and operational service for the clinical onset of subarachnoid haemorrhage.

or

14163 — the veteran has established the causal connection between the thrombolytic therapy and eligible service for the clinical onset of subarachnoid haemorrhage.

Clinical onset and operational service [14162]

12744 — the identified illness or injury for which the thrombolytic therapy was undergone is causally related to operational service.

Clinical onset and eligible service [14163]

12745 — the identified illness or injury for which the thrombolytic therapy was undergone is causally related to eligible service.